Evidence mapPaperPMID 38554170Full record

ReviewMolecular diversity2024

Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement.

Samson Lalhmangaihzuala, Khiangte Vanlaldinpuia, Vanlalngaihawma Khiangte, Zathang Laldinpuii, Thanhming Liana, Chhakchhuak Lalhriatpuia, Zodinpuia Pachuau

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular diversity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Samson LalhmangaihzualaDepartment of Chemistry, Pachhunga University College, Mizoram University, Aizawl, Mizoram, 796001, India.
Khiangte VanlaldinpuiaDepartment of Chemistry, Pachhunga University College, Mizoram University, Aizawl, Mizoram, 796001, India. mapuiakhiangte@gmail.com.
Vanlalngaihawma KhiangteDepartment of Chemistry, Pachhunga University College, Mizoram University, Aizawl, Mizoram, 796001, India.
Zathang LaldinpuiiDepartment of Chemistry, Pachhunga University College, Mizoram University, Aizawl, Mizoram, 796001, India.
Thanhming LianaDepartment of Chemistry, Pachhunga University College, Mizoram University, Aizawl, Mizoram, 796001, India.
Chhakchhuak LalhriatpuiaDepartment of Chemistry, Pachhunga University College, Mizoram University, Aizawl, Mizoram, 796001, India.
Zodinpuia PachuauDepartment of Chemistry, Mizoram University, Tanhril, Aizawl, Mizoram, 796004, India.
Mizoram University · IN

Funding

Science and Engineering Research Board CRG/2022/000821
6 · The paper itself

Abstract

Carbohydrates, one of the most abundant biomolecules found in nature, have been seen traditionally as a dietary component of foods. Recent findings, however, have unveiled their medicinal potential in the form of carbohydrates-derived drugs. Their remarkable structural diversity, high optical purity, bioavailability, low toxicity and the presence of multiple functional groups have positioned them as a valuable scaffold and an exciting frontier in contemporary therapeutics. At present, more than 170 carbohydrates-based therapeutics have been granted approval by varying regulatory agencies such as United States Food and Drug Administration (FDA), Japan Pharmaceuticals and Medical Devices Agency (PMDA), Chinese National Medical Products Administration (NMPA), and the European Medicines Agency (EMA). This article explores an overview of the fascinating potential and impact of carbohydrate-derived compounds as pharmacological agents and drug delivery vehicles.

Indexed as

CarbohydratesDrug Delivery SystemsAnimalsHumansCarbohydratesAntibioticAnticancerAntidiabetic drugAntiparasiticCarbohydrates-derived drugDrug delivery system

Identifiers

PMID38554170
OpenAlexW4393345685

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.